Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort.

[1]  Kurt Ulm,et al.  Applying competing risks regression models: an overview , 2013, Lifetime data analysis.

[2]  Jeroen J. Bax,et al.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. , 2012, European heart journal.

[3]  S. Yun,et al.  Early surgery versus conventional treatment for infective endocarditis. , 2012, The New England journal of medicine.

[4]  F. Alla,et al.  Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  D. Raoult,et al.  Management of infective endocarditis: challenges and perspectives , 2012, The Lancet.

[6]  P. Morange,et al.  Circulating Matrix Metalloproteinases in Infective Endocarditis: A Possible Marker of the Embolic Risk , 2011, PloS one.

[7]  S. Yun,et al.  Impact of Early Surgery on Embolic Events in Patients With Infective Endocarditis , 2010, Circulation.

[8]  S. Hess,et al.  Possible role of PET/CT in infective endocarditis , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[9]  B. Iung,et al.  Effect of Early Cerebral Magnetic Resonance Imaging on Clinical Decisions in Infective Endocarditis , 2010, Annals of Internal Medicine.

[10]  S. Dymarkowski,et al.  18F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  A. Mark,et al.  Subclinical Brain Embolization in Left-Sided Infective Endocarditis: Results From the Evaluation by MRI of the Brains of Patients With Left-Sided Intracardiac Solid Masses (EMBOLISM) Pilot Study , 2009, Circulation.

[12]  D. Raoult,et al.  Dramatic reduction in infective endocarditis-related mortality with a management-based approach. , 2009, Archives of internal medicine.

[13]  Ewout W. Steyerberg,et al.  Prognostic Models With Competing Risks: Methods and Application to Coronary Risk Prediction , 2009, Epidemiology.

[14]  P. Seferovic.  The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC) , 2009 .

[15]  L. Olaison,et al.  Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Stamatios Lerakis,et al.  The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). , 2007, American heart journal.

[17]  Gilbert Habib,et al.  Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. , 2007, European heart journal.

[18]  K. Bauer,et al.  The role of other hemostatic factors in predicting arterial thrombotic events. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[19]  Gilbert Habib,et al.  Risk of Embolism and Death in Infective Endocarditis: Prognostic Value of Echocardiography: A Prospective Multicenter Study , 2005, Circulation.

[20]  Patrick Royston,et al.  A new measure of prognostic separation in survival data , 2004, Statistics in medicine.

[21]  R. Levine,et al.  Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[22]  T. Durmaz,et al.  Effect of infective endocarditis on blood coagulation and platelet activation and comparison of patients with to those without embolic events. , 2003, The American journal of cardiology.

[23]  D. Sane,et al.  Aging and Thrombosis , 2002, Seminars in thrombosis and hemostasis.

[24]  Leonardo Mancini,et al.  Risk of embolization after institution of antibiotic therapy for infective endocarditis. , 2002, Journal of the American College of Cardiology.

[25]  Ş. Korkmaz,et al.  Increased levels of soluble adhesion molecules, E-selectin and P-selectin, in patients with infective endocarditis and embolic events. , 2001, European heart journal.

[26]  L. I. Kupferwasser,et al.  Echocardiography predicts embolic events in infective endocarditis. , 2001, Journal of the American College of Cardiology.

[27]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  S. Lemeshow,et al.  European system for cardiac operative risk evaluation (EuroSCORE). , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[29]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[30]  R Erbel,et al.  The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events. , 1999, Journal of the American College of Cardiology.

[31]  S. Nashef,et al.  Eurp-pean system for cardiac operative risk evaluation (Euro SCORE) , 1999 .

[32]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[33]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[34]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[35]  V T Farewell,et al.  The analysis of failure times in the presence of competing risks. , 1978, Biometrics.